The global helicobacter pylori testing market is expected to accumulate US$ 173.1 Million in value by 2022-end. During the forecast period ranging from 2022 to 2032, a CAGR worth 7.4% has been projected for the market, with an expected closing value worth US$ 380.3 Million. During the 2016 to 2021 historical period, the industry grew at a value CAGR worth 6.2%.
Growing awareness of immunodiagnostics in developed countries like the United States & Germany and increasing product approvals boost the demand for Helicobacter Pylori Testing.
| Attributes | Key Statistics |
|---|---|
| Global Helicobacter Pylori Testing Market CAGR (2022 to 2032) | 7.4% |
| Anticipated Market Value (2022) | US$ 173.1 Million |
| Global Helicobacter Pylori Testing Market (2032) | US$ 380.3 Million |
| Global Helicobacter Pylori Testing Market Attraction | People's growing awareness of immunodiagnostics, rapid advances in technology and innovation, and increasing product approvals are anticipated to propel the global helicobacter pylori testing market forward. |
Helicobacter pylori testing is used to diagnose Helicobacter pylori infections in the upper small intestine and stomach. The helicobacter pylori test is also used to evaluate treatment efficacy. Peptic ulcers, stomach (gastric) cancer, and chronic gastritis can all be caused by helicobacter pylori.
Helicobacter pylori testing is used to determine whether a helicobacter pylori infection is causing an ulcer. There are various types of helicobacter pylori testing obtainable. Some of them require a stool or breath sample, while others are more invasive and require a tissue sample obtained via endoscopy.
The bacteria Helicobacter pylori grow in the digestive tract and have a proclivity to attack the stomach lining. Helicobacter pylori infections are usually harmless, but they are responsible for the vast majority of small intestine and stomach ulcers. Because it is the most common illness in humans, early detection is critical. According to CDC research, Helicobacter pylori causes more than 90% of duodenal ulcers and up to 80% of gastric ulcers.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global helicobacter pylori testing industry is poised to increase consistently over the forecast period due to an aging population and an increase in the prevalence of infectious diseases and gastritis. People's growing awareness of immunodiagnostics, rapid advances in technology and innovation, and increasing product approvals are anticipated to propel the global helicobacter pylori testing market forward.
The advancement of newer innovations to enhance accuracy and precision has stemmed from a preference for non-invasive testing. Furthermore, non-invasive tests allow for multiple sample screenings at the same time, which a ects its acceptance rate. Reduced time, reduction of other infections during invasive testing, and less severe pain will all encourage more people to use non-invasive testing.
However, high test costs and a lack of awareness about helicobacter pylori testing are major factors restricting the growth of the global helicobacter pylori testing market.
Underdeveloped and developing countries face challenges related to a lack of healthcare resources. This results in limited access to healthcare services with insufficient facilities, which increases the likelihood of a lack of knowledge about such diseases and their diagnosis.
Principal Consultant
The market for Helicobacter pylori testing in North America is expected to take a turn for the better, attributed to the growing prevalence of H. pylori infections, rising awareness about disease diagnosis and treatment, and government initiatives to eradicate the incidence of infections.
The bacteria pose a high risk of stomach cancer, contributing to the existing disease burden, and are thus bound to grow the associated incidence and mortality among African Americans in the United States. Furthermore, advances in diagnostic technology and the inclusion of advanced healthcare infrastructure will fuel the country's growth. According to Future Market Insights, North America is likely to account for a 36.4% market share as of 2022.
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately half of the people over the age of 60 and 20% of people under the age of 40 are infected with Helicobacter Pylori in the United States. Furthermore, technological advancements in Helicobacter pylori diagnostics, as well as the presence of a well-established healthcare infrastructure, are fuelling the market's growth to a large extent.
Europe is thought to have the second-largest H. pylori testing market share, accumulating 32% revenue as of 2022. An important factor is the widespread utilization of antibiotics in many countries. In addition, rising investments and the presence of various key players are being evaluated to drive market growth.
The European market for helicobacter pylori testing is expected to be the second largest. The increasing patient pool intent on early detection of helicobacter pylori infection to avoid peptic ulcers is expected to aid market growth in the European region.
The role of H pylori in gastritis, peptic ulcers, and gastric cancer is now established, but research currently underway into possible associations with cardiovascular disease and several other conditions could guarantee a massive market in Europe for H pylori diagnostic tests and antimicrobial eradication therapy.
According to the National Institute for Health Research, the ubiquity of Helicobacter pylori is intense in most countries, including North European populations, where approximately one-third of adults are still infected, whereas, in South America, Asia, and south and east Europe, the prevalence is greater than 50%. Furthermore, Helicobacter pylori remain highly prevalent in immigrants from Helicobacter pylori-endemic countries in Europe. These factors are anticipated to propel the global helicobacter pylori testing market forward in Europe.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The swelling dispersion of start-ups in the Helicobacter Pylori Testing market has improved product quality and expanded global sales. Besides, to gain a competitive edge, new start-ups are working on innovative developments and launching new products such as:
Some key players in the Helicobacter Pylori Testing packaging market are Abbott, ADI/American Diagnostica, Agilent Technologies, Bio-Rad Laboratories, Inc., Helena Laboratories, Horiba, Takara Bio, EKF Diagnostics, Exalenz Bioscience Ltd. and Sekisui Diagnostics, LLC. A key development in the Helicobacter Pylori Testing Packaging market is as follows:
In July 2022, Bio-Rad released Platelia H. pylori IgG, an immuno-enzymatic assay for the qualitative determination of IgG antibodies. Serology provides a non-invasive, sensitive, and simple method for determining H. pylori infection. Platelia H. pylori IgG is an immunoenzymatic assay for determining the quality of IgG antibodies.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 7.4% from 2022 to 2032 |
| Market Value in 2022 | US$ 173.1 Million |
| Market Value in 2032 | US$ 380.3 Million |
| Base Year for Estimation | 2021 |
| Historical Period | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The global helicobacter pylori testing market is likely to value at US$ 173.1 Million in 2022.
The helicobacter pylori testing market is estimated to grow at a CAGR of 7.4% from 2022 to 2032.
The helicobacter pylori testing market is predicted to procure US$ 380.3 Million by 2032.
1. Executive Summary | Helicobacter Pylori Testing Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2016 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Test Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2022 to 2032
5.3.1. With Endoscopy
5.3.2. Histology
5.3.3. Rapid Urease Testing
5.3.4. Culture
5.3.5. PCR (Polymerase Chain Reaction)
5.3.6. Without Endoscopy
5.3.7. Stool/Faecal Antigen Test
5.3.8. Urea Breath Test
5.3.9. H. Pylori Antibody Testing
5.4. Y-o-Y Growth Trend Analysis By Test Type, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Test Type, 2022 to 2032
6. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
6.3.1. Hospitals
6.3.2. Private Labs
6.3.3. Public Health Labs
6.3.4. Physician Offices
6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
7. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. United States of America
8.2.1.2. Canada
8.2.2. By Test Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Test Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Test Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Test Type
9.3.3. By End User
9.4. Key Takeaways
10. Europe Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Test Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Test Type
10.3.3. By End User
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. India
11.2.1.5. Malaysia
11.2.1.6. Singapore
11.2.1.7. Australia
11.2.1.8. New Zealand
11.2.1.9. Rest of Asia-Pacific
11.2.2. By Test Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Test Type
11.3.3. By End User
11.4. Key Takeaways
12. Middle East and Africa Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of Middle East and Africa
12.2.2. By Test Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Test Type
12.3.3. By End User
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. United States of America
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Test Type
13.1.2.2. By End User
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Test Type
13.2.2.2. By End User
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Test Type
13.3.2.2. By End User
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Test Type
13.4.2.2. By End User
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Test Type
13.5.2.2. By End User
13.6. United Kingdom
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Test Type
13.6.2.2. By End User
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Test Type
13.7.2.2. By End User
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Test Type
13.8.2.2. By End User
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Test Type
13.9.2.2. By End User
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Test Type
13.10.2.2. By End User
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Test Type
13.11.2.2. By End User
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Test Type
13.12.2.2. By End User
13.13. Malaysia
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Test Type
13.13.2.2. By End User
13.14. Singapore
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Test Type
13.14.2.2. By End User
13.15. Australia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Test Type
13.15.2.2. By End User
13.16. New Zealand
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Test Type
13.16.2.2. By End User
13.17. GCC Countries
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Test Type
13.17.2.2. By End User
13.18. South Africa
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Test Type
13.18.2.2. By End User
13.19. Israel
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Test Type
13.19.2.2. By End User
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Test Type
14.3.3. By End User
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Abbott
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. ADI/American Diagnostica
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Agilent Technologies
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Bio-Rad Laboratories Inc.
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Helena Laboratories
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Horiba
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Takara Bio
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. EKF Diagnostics
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Exalenz Bioscience Ltd.
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. Sekisui Diagnostics
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Healthcare
November 2022
REP-GB-1451
250 pages
Explore Healthcare Insights
View Reports
Helicobacter Pylori Testing Market
